Literature DB >> 18006618

Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors.

Hans U Gerth1, Kai U Juergens, Uta Dirksen, Joachim Gerss, Otmar Schober, Christiane Franzius.   

Abstract

UNLABELLED: Hybrid PET/CT was compared with PET alone in the staging and restaging of patients with Ewing tumor to assess the benefit of the combined imaging technique.
METHODS: A total of 163 (18)F-FDG PET/CT studies performed in 53 patients (age: range, 4-38 y; median, 16.5 y) with histopathologically confirmed Ewing tumor were evaluated retrospectively. All PET/CT studies included low-dose CT for attenuation correction; in 91 examinations, additional diagnostic chest CT was performed. PET and CT data were assessed independently by 2 nuclear medicine physicians and 2 radiologists, respectively. Finally, both datasets were fused by use of software and analyzed by all 4 reviewers (consensus reading). Each lesion was scored with a 5-point scale. Biopsy, imaging, or clinical follow-up served as a standard of reference. Receiver operating characteristic (ROC) analyses were performed to evaluate PET and PET/CT performance characteristics. To measure the abilities to detect and correctly localize tumor foci, localization ROC (L-ROC) curves were generated for PET.
RESULTS: A total of 609 lesions were detected by PET alone. The hybrid PET/CT technique resulted in a change of score in 160 of these lesions (26%): higher scores in 23 lesions (4%) and lower scores in 137 lesions (23%). In 49 lesions detected by PET (8%), the localization had to be changed after image fusion. Additionally, 124 (21%) more lesions were found by PET/CT than by PET alone, resulting in a total of 733 lesions. As determined by lesion-based analysis, the sensitivity, specificity, and accuracy of PET were 71%, 95%, and 88%, respectively; the corresponding values for the hybrid PET/CT technique were 87%, 97%, and 94% (P < 0.0001). The areas under the curve in the ROC analysis were 0.82 for PET and 0.92 for PET/CT (P < 0.0001), and that in the L-ROC analysis was 0.66 for PET.
CONCLUSION: PET/CT is significantly more accurate than PET alone for the detection and localization of lesions and improves staging for patients with Ewing tumor. The hybrid technique is superior to PET alone in terms of sensitivity, specificity, and accuracy, mainly because of the detection of new lesions.

Entities:  

Mesh:

Year:  2007        PMID: 18006618     DOI: 10.2967/jnumed.107.045286

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  32 in total

Review 1.  Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.

Authors:  Giorgio Treglia; Marco Salsano; Antonella Stefanelli; Maria Vittoria Mattoli; Alessandro Giordano; Lorenzo Bonomo
Journal:  Skeletal Radiol       Date:  2011-11-10       Impact factor: 2.199

2.  Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.

Authors:  A Raciborska; K Bilska; K Drabko; E Michalak; R Chaber; M Pogorzała; K Połczyńska; G Sobol; M Wieczorek; K Muszyńska-Rosłan; M Rychlowska-Pruszyńska; C Rodriguez-Galindo; M Dziuk
Journal:  Clin Transl Oncol       Date:  2015-08-07       Impact factor: 3.405

Review 3.  PET/CT in paediatric oncology: indications and pitfalls.

Authors:  Christiane Franzius; Kai Uwe Juergens
Journal:  Pediatr Radiol       Date:  2009-06

Review 4.  Molecular imaging with positron emission tomography in paediatric oncology--FDG and beyond.

Authors:  Matthias Weckesser
Journal:  Pediatr Radiol       Date:  2009-06

Review 5.  Clinical and research applications of simultaneous positron emission tomography and MRI.

Authors:  F Fraioli; S Punwani
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

6.  Solitary relapse of desmoplastic small round cell tumor detected by positron emission tomography/computed tomography.

Authors:  Brian H Kushner; Michael P Laquaglia; William L Gerald; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

Review 7.  Imaging pediatric bone sarcomas.

Authors:  Sue C Kaste
Journal:  Radiol Clin North Am       Date:  2011-06-16       Impact factor: 2.303

8.  Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults.

Authors:  S Loschi; C Dufour; O Oberlin; G Goma; D Valteau-Couanet; N Gaspar
Journal:  Bone Marrow Transplant       Date:  2015-06-01       Impact factor: 5.483

Review 9.  Nuclear medicine and multimodality imaging of pediatric neuroblastoma.

Authors:  Wolfgang Peter Mueller; Eva Coppenrath; Thomas Pfluger
Journal:  Pediatr Radiol       Date:  2012-11-14

Review 10.  PET-CT imaging in pediatric oncology.

Authors:  M Beth McCarville
Journal:  Cancer Imaging       Date:  2009-06-29       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.